EMA: Two-Stage Sequential Designs [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2010-06-15 18:23 (5062 d 09:54 ago) – Posting: # 5522
Views: 14,335

Dear D. Labes!

❝ I have heard some rumor that the Potvin design C may not accepted by the EMA.

❝ Especially the unpenalized stop (without alpha spending) in the first stage if power was demonstrated >80%.

❝ Any comments from the participants of the EGA meeting (aka Klagemauer)?


Hhm, my ears were full of the screams of the desperate there and then.

Only my personal experience with two studies so far. Both protocols were approved by IECs in Berlin and without any questions concerning the method by the BfArM. I specified the method in great detail (including a graphical presentation of the decision tree) and made clear that the patient’s risk is preserved.
My interpretation of the GL calls for an α-correction only if two stages are performed and data pooled.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,657 registered users;
94 visitors (0 registered, 94 guests [including 7 identified bots]).
Forum time: 04:17 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5